These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29408369)

  • 21. Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance.
    Tye MA; Payne NC; Johansson C; Singh K; Santos SA; Fagbami L; Pant A; Sylvester K; Luth MR; Marques S; Whitman M; Mota MM; Winzeler EA; Lukens AK; Derbyshire ER; Oppermann U; Wirth DF; Mazitschek R
    Nat Commun; 2022 Aug; 13(1):4976. PubMed ID: 36008486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of protein synthesis and malaria parasite development by drug targeting of methionyl-tRNA synthetases.
    Hussain T; Yogavel M; Sharma A
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1856-67. PubMed ID: 25583729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competitive Inhibition of Okanin against
    Yang G; Liang Y; Li X; Li Z; Qin Y; Weng Q; Yan Y; Cheng Y; Qian Y; Sun L
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of Prolyl-tRNA Synthetase-Halofuginone Complex Provides Basis for Development of Drugs against Malaria and Toxoplasmosis.
    Jain V; Yogavel M; Oshima Y; Kikuchi H; Touquet B; Hakimi MA; Sharma A
    Structure; 2015 May; 23(5):819-829. PubMed ID: 25817387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as
    Okaniwa M; Shibata A; Ochida A; Akao Y; White KL; Shackleford DM; Duffy S; Lucantoni L; Dey S; Striepen J; Yeo T; Mok S; Aguiar ACC; Sturm A; Crespo B; Sanz LM; Churchyard A; Baum J; Pereira DB; Guido RVC; Dechering KJ; Wittlin S; Uhlemann AC; Fidock DA; Niles JC; Avery VM; Charman SA; Laleu B
    ACS Infect Dis; 2021 Jun; 7(6):1680-1689. PubMed ID: 33929818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic analyses of aminoacyl tRNA synthetases from human-infecting helminths.
    Goel P; Parvez S; Sharma A
    BMC Genomics; 2019 May; 20(1):333. PubMed ID: 31046663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy.
    Xie SC; Metcalfe RD; Dunn E; Morton CJ; Huang SC; Puhalovich T; Du Y; Wittlin S; Nie S; Luth MR; Ma L; Kim MS; Pasaje CFA; Kumpornsin K; Giannangelo C; Houghton FJ; Churchyard A; Famodimu MT; Barry DC; Gillett DL; Dey S; Kosasih CC; Newman W; Niles JC; Lee MCS; Baum J; Ottilie S; Winzeler EA; Creek DJ; Williamson N; Parker MW; Brand S; Langston SP; Dick LR; Griffin MDW; Gould AE; Tilley L
    Science; 2022 Jun; 376(6597):1074-1079. PubMed ID: 35653481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repurposing DrugBank compounds as potential Plasmodium falciparum class 1a aminoacyl tRNA synthetase multi-stage pan-inhibitors with a specific focus on mitomycin.
    Olotu F; Tali MBT; Chepsiror C; Sheik Amamuddy O; Boyom FF; Tastan Bishop Ö
    Int J Parasitol Drugs Drug Resist; 2024 May; 25():100548. PubMed ID: 38805932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase.
    Hewitt SN; Dranow DM; Horst BG; Abendroth JA; Forte B; Hallyburton I; Jansen C; Baragaña B; Choi R; Rivas KL; Hulverson MA; Dumais M; Edwards TE; Lorimer DD; Fairlamb AH; Gray DW; Read KD; Lehane AM; Kirk K; Myler PJ; Wernimont A; Walpole C; Stacy R; Barrett LK; Gilbert IH; Van Voorhis WC
    ACS Infect Dis; 2017 Jan; 3(1):34-44. PubMed ID: 27798837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploration of aminoacyl-tRNA synthetases from eukaryotic parasites for drug development.
    Gill J; Sharma A
    J Biol Chem; 2023 Mar; 299(3):102860. PubMed ID: 36596362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dual-targeted aminoacyl-tRNA synthetase in Plasmodium falciparum charges cytosolic and apicoplast tRNACys.
    Pham JS; Sakaguchi R; Yeoh LM; De Silva NS; McFadden GI; Hou YM; Ralph SA
    Biochem J; 2014 Mar; 458(3):513-23. PubMed ID: 24428730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminoacyl-tRNA synthetases as drug targets.
    Lukarska M; Palencia A
    Enzymes; 2020; 48():321-350. PubMed ID: 33837708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation.
    Pandey RK; Narula A; Naskar M; Srivastava S; Verma P; Malik R; Shah P; Prajapati VK
    J Biomol Struct Dyn; 2017 Mar; 35(4):791-804. PubMed ID: 26984239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors.
    Murillo-Solano C; Dong C; Sanchez CG; Pizarro JC
    Malar J; 2017 Jul; 16(1):292. PubMed ID: 28724415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminoacylation of Plasmodium falciparum tRNA(Asn) and insights in the synthesis of asparagine repeats.
    Filisetti D; Théobald-Dietrich A; Mahmoudi N; Rudinger-Thirion J; Candolfi E; Frugier M
    J Biol Chem; 2013 Dec; 288(51):36361-71. PubMed ID: 24196969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Plasmodium falciparum phenylalanine tRNA synthetase provides opportunity for antimalarial drug development.
    Sharma M; Mutharasappan N; Manickam Y; Harlos K; Melillo B; Comer E; Tabassum H; Parvez S; Schreiber SL; Sharma A
    Structure; 2022 Jul; 30(7):962-972.e3. PubMed ID: 35460612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structures of Plasmodium falciparum cytosolic tryptophanyl-tRNA synthetase and its potential as a target for structure-guided drug design.
    Koh CY; Kim JE; Napoli AJ; Verlinde CL; Fan E; Buckner FS; Van Voorhis WC; Hol WG
    Mol Biochem Parasitol; 2013 May; 189(1-2):26-32. PubMed ID: 23665145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico assessment of natural products and approved drugs as potential inhibitory scaffolds targeting aminoacyl-tRNA synthetases from
    Doshi K; Pandya N; Datt M
    3 Biotech; 2020 Nov; 10(11):470. PubMed ID: 33088666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolutionary and structural annotation of disease-associated mutations in human aminoacyl-tRNA synthetases.
    Datt M; Sharma A
    BMC Genomics; 2014 Dec; 15(1):1063. PubMed ID: 25476837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin.
    Hoepfner D; McNamara CW; Lim CS; Studer C; Riedl R; Aust T; McCormack SL; Plouffe DM; Meister S; Schuierer S; Plikat U; Hartmann N; Staedtler F; Cotesta S; Schmitt EK; Petersen F; Supek F; Glynne RJ; Tallarico JA; Porter JA; Fishman MC; Bodenreider C; Diagana TT; Movva NR; Winzeler EA
    Cell Host Microbe; 2012 Jun; 11(6):654-63. PubMed ID: 22704625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.